A previous study showed that NAFLD and T2DM patients share some pathophysiological characteristics [14], such as insulin resistance, abnormal insulin secretion, epigenetic alterations, glucose and lipid metabolism disorders, and factors related to lifestyle [14], suggesting that liraglutide can also be used for treating NAFLD. The gene discussed is INS; the disease is type 2 diabetes mellitus.